Type i IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human

International Journal of Cancer

Volumn 138, Issue 8, 2016, Pages 1982-1993

  Andzinski, Lisa ^a   Kasnitz, Nadine ^a   Stahnke, Stephanie ^a   Wu, Ching Fang ^a,b   Gereke, Marcus ^a,c   Von Köckritz Blickwede, Maren ^d   Schilling, Bastian ^e,f   Brandau, Sven ^f,g   Weiss, Siegfried ^a,h   Jablonska, Jadwiga ^a,i  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b E DA HOSPITAL   (Taiwan)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g UNIVERSITY OF DUISBURG ESSEN   (Germany)

^h HANNOVER MEDICAL SCHOOL   (Germany)

ⁱ UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

IFN ; melanoma; neutrophils; polarization; tumor

Indexed keywords

BETA INTERFERON; CD86 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON; RECOMBINANT ALPHA2 INTERFERON; RECOMBINANT BETA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CELL KILLING; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EXTRACELLULAR TRAP; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LOW DRUG DOSE; MELANOMA; MOUSE; NEOPLASM; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; SUPPRESSOR CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; ANIMAL; BAGG ALBINO MOUSE; CELL SEPARATION; DRUG EFFECTS; EXPERIMENTAL NEOPLASM; FLOW CYTOMETRY; IMMUNOLOGY; KNOCKOUT MOUSE; NEUTROPHIL; PATHOLOGY; PHENOTYPE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE I; MELANOMA; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; NEUTROPHIL INFILTRATION; NEUTROPHILS; PHENOTYPE;

EID: 84958925156     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29945     Document Type: Article

References (49)

1. Fridlender ZG, Sun J, Kim S, et al., Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009; 16: 183-94. 2009/09/08ed.
2. Mishalian I, Bayuh R, Levy L, et al., Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression. Cancer Immunol Immunother 2013; 62: 1745-56.
3. Tazawa H, Okada F, Kobayashi T, et al., Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression. Am J Pathol 2003; 163: 2221-32.
4. Jablonska J, Leschner S, Westphal K, et al., Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J Clin Invest 2010; 120: 1151-64.
5. Wu C-F, Andzinski L, Kasnitz N, et al, The lack of type I interferon induces neutrophil-mediated pre-metastatic niche formation in the mouse lung. Int J Cancer 2015; 137: 837-47.
6. Hicks AM, Riedlinger G, Willingham MC, et al., Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc Natl Acad Sci USA 2006; 103: 7753-8.
7. Granot Z, Henke E, Comen EA, et al., Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell 2011; 20: 300-14.
8. Mittendorf EA, Alatrash G, Qiao N, et al., Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response. Cancer Res 2012; 72: 3153-62.
9. Zivkovic M, Poljak-Blazi M, Zarkovic K, et al., Oxidative burst of neutrophils against melanoma B16-F10. Cancer Lett 2007; 246: 100-8.
10. Scapini P, Lapinet-Vera JA, Gasperini S, et al., The neutrophil as a cellular source of chemokines. Immunol Rev 2000; 177: 195-203.
11. Beauvillain C, Delneste Y, Scotet M, et al., Neutrophils efficiently cross-prime naive T cells in vivo. Blood 2007; 110: 2965-73.
12. Fridlender ZG, Albelda SM., Tumor-associated neutrophils: friend or foe? Carcinogenesis 2012; 33: 949-55.
13. Jablonska J, Wu C-F, Andzinski L, et al., CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-β. Int J Cancer 2013; 134: 1346-58.
14. Andzinski L, Wu C-F, Lienenklaus S, et al., Delayed apoptosis of tumor associated neutrophils in the absence of endogenous IFN-β. Int J Cancer 2014; 136: 572-83.
15. Amulic B, Cazalet C, Hayes GL, et al., Neutrophil function: from mechanisms to disease. Annu Rev Immunol. 2012; 30: 459-89.
16. Mayadas TN, Cullere X, Lowell CA., The multifaceted functions of neutrophils. Annu Rev Pathol 2014; 9: 181-218.
17. Elbim C, Estaquier J., Cytokines modulate neutrophil death. Eur Cytokine Netw 2010; 21: 1-6.
18. Mantovani A, Cassatella MA, Costantini C, et al., Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011; 11: 519-31.
19. Piccard H, Muschel RJ, Opdenakker G., On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit Rev Oncol Hematol 2012; 82: 296-309.
20. Fortunati E, Kazemier KM, Grutters JC, et al., Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease. Clin Exp Immunol 2009; 155: 559-66.
21. Pillay J, Kamp VM, van Hoffen E, et al., A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest 2012; 122: 327-36.
22. Berger-Achituv S, Brinkmann V, Abed UA, et al., A proposed role for neutrophil extracellular traps in cancer immunoediting. Front Immunol 2013; 4: 48.
23. Akong-Moore K, Chow OA, von Köckritz-Blickwede M, et al., Influences of chloride and hypochlorite on neutrophil extracellular trap formation. PLoS One 2012; 7: e42984.
24. Balkwill F., Tumour necrosis factor and cancer. Nat Rev Cancer 2009; 9: 361-71.
25. Li Q, Li L, Shi W, et al., Mechanism of action differences in the antitumor effects of transmembrane and secretory tumor necrosis factor-alpha in vitro and in vivo. Cancer Immunol Immunother 2006; 55: 1470-9.
26. Kiladjian JJ, Mesa RA, Hoffman R., The renaissance of interferon therapy for the treatment of myeloid malignancies. Blood 2011; 117: 4706-15.
27. Mocellin S, Lens MB, Pasquali S, et al., Interferon alpha for the adjuvant treatment of cutaneous melanoma. Cochrane Database Syst Rev 2013; 6: CD008955.
28. Gupta GP, Massagué J., Cancer metastasis: building a framework. Cell 2006; 127: 679-95.
29. Sceneay J, Smyth MJ, Möller A., The pre-metastatic niche: finding common ground. Cancer Metastasis Rev 2013; 32: 449-64.
30. Kowanetz M, Wu X, Lee J, et al., Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc Natl Acad Sci USA 2010; 107: 21248-55.
31. Smith MCP, Luker KE, Garbow JR, et al., CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 2004; 64: 8604-12.
32. Dumitru CA, Moses K, Trellakis S, et al., Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol Immunother 2012; 61: 1155-67.
33. Brandau S, Moses K, Lang S., The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins? Semin Cancer Biol 2013; 23: 171-82.
34. Jensen HK, Donskov F, Marcussen N, et al., Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J Clin Oncol 2009; 27: 4709-17.
35. Stark MA, Huo Y, Burcin TL, et al., Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005; 22: 285-94.
36. Chen M, Chen G, Nie H, et al., Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS. Eur J Immunol 2009; 39: 2525-36.
37. Lebedeva T, Dustin ML, Sykulev Y., ICAM-1 co-stimulates target cells to facilitate antigen presentation. Curr Opin Immunol 2005; 17: 251-8.
38. Chen T, Goldstein JS, O'Boyle K, et al., ICAM-1 co-stimulation has differential effects on the activation of CD4+ and CD8+ T cells. Eur J Immunol 1999; 29: 809-14.
39. Labuda T, Wendt J, Hedlund G, et al., ICAM-1 costimulation induces IL-2 but inhibits IL-10 production in superantigen-activated human CD4+ T cells. Immunology 1998; 94: 496-502.
40. Ferrante A., Activation of neutrophils by interleukins-1 and -2 and tumor necrosis factors. Immunol Ser 1992; 57: 417-36.
41. Gerrard TL, Cohen DJ, Kaplan AM., Human neutrophil-mediated cytotoxicity to tumor cells. J Natl Cancer Inst 1981; 66: 483-8.
42. Cools-Lartigue J, Spicer J, McDonald B, et al., Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest 2013; 123: 3446-58.
43. Zivkovic M, Poljak-Blazi M, Egger G, et al., Oxidative burst and anticancer activities of rat neutrophils. Biofactors 2005; 24: 305-12.
44. Kousis PC, Henderson BW, Maier PG, et al., Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils. Cancer Res. 2007; 67: 10501-10.
45. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V., Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12: 253-68.
46. Jang SH, Wientjes MG, Lu D, et al., Drug delivery and transport to solid tumors. Pharm Res 2003; 20: 1337-50.
47. Sagiv JY, Michaeli J, Assi S, et al., Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep 2015; 10: 562-73.
48. Schilling B, Sucker A, Griewank K, et al., Vemurafenib reverses immunosuppression by myeloid derived suppressor cells. Int J Cancer 2013; 133: 1653-63.
49. Trellakis S, Farjah H, Bruderek K, et al., Peripheral blood neutrophil granulocytes from patients with head and neck squamous cell carcinoma functionally differ from their counterparts in healthy donors. Int J Immunopathol Pharmacol 2011; 24: 683-93.